KRAS and neoplasm: In cancer cells, KRAS-induced loss of cilia establishes asymmetry versus ciliated mesenchymal cells in the tumor microenvironment, affecting ability to respond to Hh, which selectively activates CAFs to produce the extracellular matrix and soluble factors required to support tumor growth [176].